Retinol-binding protein levels are increased in association with gonadotropin levels in healthy women

Metabolism: Clinical and Experimental

Volumn 58, Issue 4, 2009, Pages 479-487

  Makimura, Hideo ^a   Wei, Jeffrey ^a   Dolan Looby, Sara E ^a   Ricchiuti, Vincent ^b   Grinspoon, Steven ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADOTROPIN; INSULIN; LUTEINIZING HORMONE; PRASTERONE; RETINOL BINDING PROTEIN 4; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; FEMALE; GLUCOSE TOLERANCE; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GONADOTROPINS; HUMANS; MENOPAUSE; REFERENCE VALUES; RETINOL-BINDING PROTEINS;

EID: 62349088005     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.11.004     Document Type: Article

References (33)

1. Yang Q., Graham T.E., Mody N., Preitner F., Peroni O.D., Zabolotny J.M., et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436 (2005) 356-362
2. Graham T.E., Yang Q., Bluher M., Hammarstedt A., Ciaraldi T.P., Henry R.R., et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 354 (2006) 2552-2563
3. Cho Y.M., Youn B.S., Lee H., Lee N., Min S.S., Kwak S.H., et al. Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes. Diabetes Care 29 (2006) 2457-2461
4. Gavi S., Stuart L.M., Kelly P., Melendez M.M., Mynarcik D.C., Gelato M.C., et al. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes. J Clin Endocrinol Metab 92 (2007) 1886-1890
5. Stefan N., Hennige A.M., Staiger H., Machann J., Schick F., Schleicher E., et al. High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans. Diabetes Care 30 (2007) 1173-1178
6. Jia W., Wu H., Bao Y., Wang C., Lu J., Zhu J., et al. Association of serum retinol-binding protein 4 and visceral adiposity in Chinese subjects with and without type 2 diabetes. J Clin Endocrinol Metab 92 (2007) 3224-3229
7. Balagopal P., Graham T.E., Kahn B.B., Altomare A., Funanage V., and George D. Reduction of elevated serum retinol binding protein in obese children by lifestyle intervention: association with subclinical inflammation. J Clin Endocrinol Metab 92 (2007) 1971-1974
8. Lee D.C., Lee J.W., and Im J.A. Association of serum retinol binding protein 4 and insulin resistance in apparently healthy adolescents. Metabolism 56 (2007) 327-331
9. Janke J., Engeli S., Boschmann M., Adams F., Bohnke J., Luft F.C., et al. Retinol-binding protein 4 in human obesity. Diabetes 55 (2006) 2805-2810
10. Takebayashi K., Suetsugu M., Wakabayashi S., Aso Y., and Inukai T. Retinol binding protein-4 levels and clinical features of type 2 diabetes patients. J Clin Endocrinol Metab 92 (2007) 2712-2719
11. Yao-Borengasser A., Varma V., Bodles A.M., Rasouli N., Phanavanh B., Lee M.J., et al. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 92 (2007) 2590-2597
12. Weiping L., Qingfeng C., Shikun M., Xiurong L., Hua Q., Xiaoshu B., et al. Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome. Endocrine 30 (2006) 283-287
13. Tan B.K., Chen J., Lehnert H., Kennedy R., and Randeva H.S. Raised serum, adipocyte, and adipose tissue retinol-binding protein 4 in overweight women with polycystic ovary syndrome: effects of gonadal and adrenal steroids. J Clin Endocrinol Metab 92 (2007) 2764-2772
14. Pedersen S.B., Bruun J.M., Hube F., Kristensen K., Hauner H., and Richelsen B. Demonstration of estrogen receptor subtypes alpha and beta in human adipose tissue: influences of adipose cell differentiation and fat depot localization. Mol Cell Endocrinol 182 (2001) 27-37
15. Dieudonne M.N., Pecquery R., Boumediene A., Leneveu M.C., and Giudicelli Y. Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids. Am J Physiol 274 6 Pt 1 (1998) C1645-C1652
16. Schaffler A., Binart N., Scholmerich J., and Buchler C. Hypothesis paper. Brain talks with fat-evidence for a hypothalamic-pituitary-adipose axis?. Neuropeptides 39 (2005) 363-367
17. Schaffler A., Scholmerich J., and Buechler C. The role of 'adipotropins' and the clinical importance of a potential hypothalamic-pituitary-adipose axis. Nat Clin Pract Endocrinol Metab 2 (2006) 374-383
18. Dos Santos E., Dieudonne M.N., Leneveu M.C., Pecquery R., Serazin V., and Giudicelli Y. In vitro effects of chorionic gonadotropin hormone on human adipose development. J Endocrinol 194 (2007) 313-325
19. Lo J., Dolan S.E., Kanter J.R., Hemphill L.C., Connelly J.M., Lees R.S., et al. Effects of obesity, body composition, and adiponectin on carotid intima-media thickness in healthy women. J Clin Endocrinol Metab 91 (2006) 1677-1682
20. Weyer C., Funahashi T., Tanaka S., Hotta K., Matsuzawa Y., Pratley R.E., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
21. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20 (2000) 1595-1599
22. Kumada M., Kihara S., Sumitsuji S., Kawamoto T., Matsumoto S., Ouchi N., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23 (2003) 85-89
23. Ouchi N., Kihara S., Arita Y., Okamoto Y., Maeda K., Kuriyama H., et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation 102 (2000) 1296-1301
24. Ouchi N., Kihara S., Arita Y., Nishida M., Matsuyama A., Okamoto Y., et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation 103 (2001) 1057-1063
25. Johnsen S., Dolan S.E., Fitch K.V., Kanter J.R., Hemphill L.C., Connelly J.M., et al. Carotid intimal medial thickness in HIV infected women: effects of protease inhibitor use, cardiac risk factors and the metabolic syndrome. J Clin Endocrinol Metab 91 (2006) 4916-4924
26. Chan R., Kaufhold J., Hemphill L.C., Lees R.S., and Karl W.C. Anisotropic edge-preserving smoothing in carotid B-mod ultrasound for improved segmentation and intima-media thickness (IMT) measurement. Comput Cardiol 27 (2000) 37-40
27. Soprano D.R., Soprano K.J., and Goodman D.S. Retinol-binding protein messenger RNA levels in the liver and in extrahepatic tissues of the rat. J Lipid Res 27 (1986) 166-171
28. Lindheim S.R., Buchanan T.A., Duffy D.M., Vijod M.A., Kojima T., Stanczyk F.Z., et al. Comparison of estimates of insulin sensitivity in pre- and postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test. J Soc Gynecol Investig 1 (1994) 150-154
29. Kanaley J.A., Sames C., Swisher L., Swick A.G., Ploutz-Snyder L.L., Steppan C.M., et al. Abdominal fat distribution in pre- and postmenopausal women: the impact of physical activity, age, and menopausal status. Metabolism 50 (2001) 976-982
30. Toth M.J., Tchernof A., Sites C.K., and Poehlman E.T. Effect of menopausal status on body composition and abdominal fat distribution. Int J Obes Relat Metab Disord 24 (2000) 226-231
31. Carr M.C. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88 (2003) 2404-2411
32. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 444 (2006) 860-867
33. Graham T.E., Wason C.J., Bluher M., and Kahn B.B. Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects. Diabetologia 50 (2007) 814-823